CRDF - Cardiff Oncology GAAP EPS of -$0.89 beats by $0.05 revenue of $0.39M beats by $0.12M March, 02 2023 04:36 PM Cardiff Oncology Inc. Cardiff Oncology press release ( NASDAQ: CRDF ): FY GAAP EPS of -$0.89 beats by $0.05 . Revenue of $0.39M (+8.3% Y/Y) beats by $0.12M . For further details see: Cardiff Oncology GAAP EPS of -$0.89 beats by $0.05, revenue of $0.39M beats by $0.12M